Prostate Cancer TopicsShow More
Researchers have been working on a tool that can identify low- and high-risk prostate cancer more accurately.
Dana Clark, M.S., L.C.G.C., at the Basser Center for BRCA at Penn Medicine, discusses when you’re at a high risk for BRCA gene mutations, what testing involves, and what misconceptions she commonly encounters.
Looking at how prostate cancer tumors change over time may help determine how aggressive the cancer is and how it should be treated, according to a new study.
Cancer screening is less straightforward than it might seem. Screening isn’t routinely recommended for some cancers, and has confusing guidelines about others.
Should you be screened for prostate cancer? These new guidelines say no if you're older than 70.
A prostate biopsy, performed on an outpatient basis, takes about 20 minutes and is used to diagnose or rule out prostate cancer. Here’s what to expect.
Prostate cancer is a serious and common health problem among American men. Here's what you should know, including symptoms, screening, and diagnosis.
The TNM staging system describes how far prostate cancer has spread and helps determine appropriate treatment options.
If you have prostate cancer, your Gleason score helps you understand how aggressive the cancer is, and it helps you choose the best treatment.
There are many tests out there to help diagnose prostate cancer, but it’s not yet clear how useful they are. Here’s what to consider.